Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 8—August 2011
CME ACTIVITY - Research

Deaths Associated with Human Adenovirus-14p1 Infections, Europe, 2009–2010

Michael J. CarrComments to Author , Adriana E. Kajon, Xiaoyan Lu, Linda Dunford, Paul O’Reilly, Paul Holder, Cillian F. De Gascun, Suzie Coughlan, Jeff Connell, Dean D. Erdman, and William W. Hall
Author affiliations: Author affiliations: National Virus Reference Laboratory–University College Dublin, Dublin, Ireland (M.J. Carr, L. Dunford, P. O’Reilly, P. Holder, C.F. De Gascun, S. Coughlan, J. Connell, W.W. Hall); Lovelace Respiratory Research Institute, Albuquerque, New Mexico, USA (A.E. Kajon); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (X. Lu, D.D. Erdman)

Main Article

Figure 1

Maximum-likelihood trees of the full-length fiber (A), E1A (B), and hexon (C) open reading frames of adenovirus B2 subgenera. Phylogenetic analysis was performed by using reference sequences from GenBank for the adenovirus B2 subgenera, including prototype reference strains. The query sequences from this study are identical and are represented in boldface. The tree was built in PAUP* (23) on the basis of the HKY85 model of evolution and for the fiber tree also with a β distribution and used midp

Figure 1. Maximum-likelihood trees of the full-length fiber (A), E1A (B), and hexon (C) open reading frames of adenovirus B2 subgenera. Phylogenetic analysis was performed by using reference sequences from GenBank for the adenovirus B2 subgenera, including prototype reference strains. The query sequences from this study are identical and are represented in boldface. The tree was built in PAUP* (23) on the basis of the HKY85 model of evolution and for the fiber tree also with a β distribution and used midpoint rooting. Bootstrap resampling (n = 1,000) was performed by using the neighbor-joining algorithm. Scale bars indicate nucleotide substitutions per site.

Main Article

References
  1. Rowe  WP, Huebner  RJ, Gilmore  LK, Parrott  RH, Ward  TJ. Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med. 1953;84:570–3.PubMedGoogle Scholar
  2. Hilleman  MR. Recovery of new agent from patients with acute respiratory illness. Proc Soc Exp Biol Med. 1954;85:183–8.PubMedGoogle Scholar
  3. Wold  WSM, Horwitz  MS. Adenoviruses. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology. 5th ed. Philadelphia (PA): Lippincott-Raven; 2007. p. 2395–436.
  4. Baum  SG. Adenoviruses. In: Mandell GL, Bennett JE, Dolin R. editors. Principles and practice of infectious diseases. 5th ed. Vol 2. Philadelphia (PA): Churchill Livingstone; 2005. p. 1835–41.
  5. Van Der Veen  J, Kok  G. Isolation and typing of adenoviruses recovered from military recruits with acute respiratory disease in the Netherlands. Am J Hyg. 1957;65:119–29.PubMedGoogle Scholar
  6. Kendall  EJ, Riddle  RW, Tuck  HA, Rodan  KS, Andrews  BE, McDonald  JC. Pharyngo-conjunctival fever; school outbreaks in England during the summer of 1955 associated with adenovirus types 3, 7, and 14. BMJ. 1957;2:131–6. DOIPubMedGoogle Scholar
  7. Kajon  AE, Lu  X, Erdman  DD, Louie  J, Schnurr  D, George  KS, Molecular epidemiology and brief history of emerging adenovirus 14–associated respiratory disease in the United States. J Infect Dis. 2010;202:93–103. DOIPubMedGoogle Scholar
  8. Metzgar  D, Osuna  M, Kajon  AE, Hawksworth  AW, Irvine  M, Russell  KL. Abrupt emergence of diverse species B adenoviruses at US military recruit training centers. J Infect Dis. 2007;196:1465–73. DOIPubMedGoogle Scholar
  9. Centers for Disease Control and Prevention. Acute respiratory disease associated with adenovirus serotype 14—four states, 2006–2007. MMWR Morb Mortal Wkly Rep. 2007;56:1181–4.PubMedGoogle Scholar
  10. Louie  JK, Kajon  AE, Holodniy  M, Guardia-LaBar  L, Lee  B, Petru  AM, Severe pneumonia due to adenovirus serotype 14: a new respiratory threat? Clin Infect Dis. 2008;46:421–5. DOIPubMedGoogle Scholar
  11. Esposito  DH, Gardner  TJ, Schneider  E, Stockman  LJ, Tate  JE, Panozzo  CA, Outbreak of pneumonia associated with emergent human adenovirus serotype 14—southeast Alaska, 2008. J Infect Dis. 2010;202:214–22. DOIPubMedGoogle Scholar
  12. Wang  H, Tuve  S, Erdman  DD, Lieber  A. Receptor usage of a newly emergent adenovirus type 14. Virology. 2009;387:436–41. DOIPubMedGoogle Scholar
  13. Houng  HS, Gong  H, Kajon  AE, Jones  MS, Kuschner  RA, Lyons  A, Genome sequences of human adenovirus 14 isolates from mild respiratory cases and a fatal pneumonia, isolated during 2006–2007 epidemics in North America. Respir Res. 2010;11:116. DOIPubMedGoogle Scholar
  14. Hierholzer  JC, Pumarola  A. Antigenic characterization of intermediate adenovirus 14–11 strains associated with upper respiratory illness in a military camp. Infect Immun. 1976;13:354–9.PubMedGoogle Scholar
  15. Chmielewicz  B, Benzler  J, Pauli  G, Krause  G, Bergmann  F, Schweiger  B. Respiratory disease caused by a species B2 adenovirus in a military camp in Turkey. J Med Virol. 2005;77:232–7. DOIPubMedGoogle Scholar
  16. Kajon  AE, Erdman  DD. Assessment of genetic variability among subspecies B1 human adenoviruses for molecular epidemiology studies. In: Wold W, Tollefsson A, editors. Adenovirus methods and protocols. 2nd ed. Vol 2. Totowa (NJ): Humana Press; 2007. p. 335–55.
  17. Treacy  A, Carr  MJ, Dunford  L, Palacios  G, Cannon  GA, O’Grady  A, First report of sudden death due to myocarditis caused by adenovirus serotype 3. J Clin Microbiol. 2010;48:642–5. DOIPubMedGoogle Scholar
  18. Casas  I, Avellon  A, Mosquera  M, Jabado  O, Echevarria  JE, Campos  RH, Molecular identification of adenoviruses in clinical samples by analyzing a partial hexon genomic region. J Clin Microbiol. 2005;43:6176–82. DOIPubMedGoogle Scholar
  19. Lewis  PF, Schmidt  MA, Lu  X, Erdman  DD, Campbell  M, Thomas  A, A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14. J Infect Dis. 2009;199:1427–34. DOIPubMedGoogle Scholar
  20. Burland  TG. DNASTAR's Lasergene sequence analysis software. Methods Mol Biol. 2000;132:71–91.PubMedGoogle Scholar
  21. Thompson  JD, Higgins  DG, Gibson  TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994;22:4673–80. DOIPubMedGoogle Scholar
  22. Hall  TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser. 1999;41:95–8.
  23. Swofford  DL. PAUP*: phylogenetic analysis using parsimony (*and other methods), version 4.0 β 10. Sunderland (MA): Sinauer Associates; 2003.
  24. Hakim  FA, Tleyjeh  IM. Severe adenovirus pneumonia in immunocompetent adults: a case report and review of the literature. Eur J Clin Microbiol Infect Dis. 2008;27:153–8. DOIPubMedGoogle Scholar
  25. Tate  JE, Bunning  ML, Lott  L, Lu  X, Su  J, Metzgar  D, Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US Air Force training facility in 2007. J Infect Dis. 2009;199:1419–26. DOIPubMedGoogle Scholar
  26. Centers for Disease Control and Prevention. Outbreak of adenovirus 14 respiratory illness—Prince of Wales Island, Alaska, 2008. MMWR Morb Mortal Wkly Rep. 2010;59:6–10.PubMedGoogle Scholar
  27. Lyons  A, Longfield  J, Kuschner  R, Straight  T, Binn  L, Seriwatana  J, A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults. Vaccine. 2008;26:2890–8. DOIPubMedGoogle Scholar
  28. Russell  KL, Hawksworth  AW, Ryan  MA, Strickler  J, Irvine  M, Hansen  CJ, Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999–2004. Vaccine. 2006;24:2835–42. DOIPubMedGoogle Scholar
  29. Trei  JS, Johns  NM, Garner  JL, Noel  LB, Ortman  BV, Ensz  KL, Spread of adenovirus to geographically dispersed military installations, May–October 2007. Emerg Infect Dis. 2010;16:769–75.PubMedGoogle Scholar

Main Article

Page created: September 01, 2011
Page updated: September 01, 2011
Page reviewed: September 01, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external